Product Delivery

Leaders expand their product delivery approach to boost access for lower-income countries

Novartis leads the way as the only company that implements an equitable strategy in lower-income countries for all products analysed. Overall, Novartis and GSK target multiple countries and patient populations across the income pyramid with their access strategies, e.g., equitable pricing and responsible IP management. Furthermore, they both leverage their know-how and resources to address local access barriers through their capacity building initiatives.

1 Novartis AG
0 1 2 3 4 5
4.53

Novartis AG

Read more
2 GlaxoSmithKline plc
0 1 2 3 4 5
4.36

GlaxoSmithKline plc

Read more
3 Pfizer Inc.
0 1 2 3 4 5
3.91

Pfizer Inc.

Read more
3 Sanofi
0 1 2 3 4 5
3.91

Sanofi

Read more
4 Novo Nordisk A/S
0 1 2 3 4 5
3.81

Novo Nordisk A/S

Read more
5 Johnson & Johnson
0 1 2 3 4 5
3.78

Johnson & Johnson

Read more
6 AstraZeneca plc
0 1 2 3 4 5
3.29

AstraZeneca plc

Read more
7 Takeda Pharmaceutical Co. Ltd.
0 1 2 3 4 5
3.22

Takeda Pharmaceutical Co. Ltd.

Read more
8 Merck KGaA (Merck)
0 1 2 3 4 5
3.16

Merck KGaA (Merck)

Read more
9 Boehringer Ingelheim GmbH
0 1 2 3 4 5
3.09

Boehringer Ingelheim GmbH

Read more
10 Eisai Co. Ltd.
0 1 2 3 4 5
3.06

Eisai Co. Ltd.

Read more
11 Bayer AG
0 1 2 3 4 5
3.03

Bayer AG

Read more
12 Roche Holding AG
0 1 2 3 4 5
2.92

Roche Holding AG

Read more
13 Gilead Sciences Inc.
0 1 2 3 4 5
2.50

Gilead Sciences Inc.

Read more
14 Astellas Pharma Inc.
0 1 2 3 4 5
2.35

Astellas Pharma Inc.

Read more
15 Daiichi Sankyo Co. Ltd.
0 1 2 3 4 5
1.90

Daiichi Sankyo Co. Ltd.

Read more
16 Merck & Co., Inc. (MSD)
0 1 2 3 4 5
1.82

Merck & Co., Inc. (MSD)

Read more
17 AbbVie Inc.
0 1 2 3 4 5
1.30

AbbVie Inc.

Read more
18 Eli Lilly & Co.
0 1 2 3 4 5
1.25

Eli Lilly & Co.

Read more
19 Bristol Myers Squibb Co.
0 1 2 3 4 5
1.15

Bristol Myers Squibb Co.

Read more
0 1 2 3 4 5

The ranking above shows the position and score of each company in the 2021 Index. Click on a company's name to go to its full report card.

Get in touch

Back to top |